Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Esplanade Ventures is a venture capital firm based in Canada, founded in 2019 by a team with over 100 years of collective experience in healthcare operations, founding, and investment. The firm focuses on technology companies that are transforming healthcare delivery across the U.S. and Canada. Specific metrics such as fund size or assets under management are not disclosed.
Esplanade Ventures invests in early-stage and high-growth companies, particularly those developing digital health solutions with a preference for AI-enabled technologies. The firm typically engages in Seed to Series A rounds, with selective Series B investments. They concentrate on companies commercializing in North America and do not invest in invasive devices or biotech.
Submit your pitch through their form at esplanadeventures.com.
Esplanade Ventures often leads Seed and Series A rounds, providing initial capital and strategic guidance to portfolio companies.
The firm is open to follow-on investments, particularly in Series B rounds, depending on the growth trajectory and needs of the portfolio companies.
Esplanade Ventures distinguishes itself by focusing exclusively on digital health solutions and AI technologies, avoiding invasive devices and biotech, which allows for a concentrated investment strategy.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.